{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:17:47Z","timestamp":1790533067881,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1124\/jpet.112.202010","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T04:23:25Z","timestamp":1360815805000},"page":"297-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C&gt;G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a\/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure"],"prefix":"10.1016","volume":"345","author":[{"given":"Michael H.","family":"Court","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Freytsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Guillemette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suwagmani","family":"Hazarika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su X.","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"the Acute Liver Failure Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.202010_bib1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.tpj.6500123","article-title":"Pharmacogenetic analysis of adverse drug effect reveals genetic variant for susceptibility to liver toxicity","volume":"2","author":"Acu\u00f1a","year":"2002","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/jpet.112.202010_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1124\/jpet.112.202010_bib3","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1074\/jbc.M109.083139","article-title":"Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions","volume":"285","author":"Bellemare","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.112.202010_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/tpj.2009.64","article-title":"Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell lines","volume":"10","author":"Bellemare","year":"2010","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/jpet.112.202010_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/dmd.108.023101","article-title":"Deferiprone glucuronidation by human tissues and recombinant UDP glucuronosyltransferase 1A6: an in vitro investigation of genetic and splice variants","volume":"37","author":"Benoit-Biancamano","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.202010_bib6","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/0006-2952(93)90437-2","article-title":"Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases","volume":"45","author":"Bock","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.112.202010_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/15563650.2011.639713","article-title":"The role of the glutathione S-transferase genes GSTT1, GSTM1, and GSTP1 in acetaminophen-poisoned patients","volume":"50","author":"Buchard","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1124\/jpet.112.202010_bib8","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1093\/nar\/gkg616","article-title":"ESEfinder: a web resource to identify exonic splicing enhancers","volume":"31","author":"Cartegni","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/jpet.112.202010_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/03602530903209288","article-title":"Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system","volume":"42","author":"Court","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1124\/jpet.112.202010_bib10","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0022-3565(24)29222-3","article-title":"Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms","volume":"299","author":"Court","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.202010_bib11","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1124\/jpet.104.067660","article-title":"UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver","volume":"310","author":"Court","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.202010_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/(SICI)1099-081X(199704)18:3<213::AID-BDD15>3.0.CO;2-0","article-title":"Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species","volume":"18","author":"Court","year":"1997","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/jpet.112.202010_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/00498254.2011.618954","article-title":"Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues","volume":"42","author":"Court","year":"2012","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.112.202010_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2710.2004.00626.x","article-title":"Differences in the single-oral-dose pharmacokinetics and urinary excretion of paracetamol and its conjugates between Hong Kong Chinese and Caucasian subjects","volume":"30","author":"Critchley","year":"2005","journal-title":"J Clin Pharm Ther"},{"key":"10.1124\/jpet.112.202010_bib15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2125.1986.tb02953.x","article-title":"Inter-subject and ethnic differences in paracetamol metabolism","volume":"22","author":"Critchley","year":"1986","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.112.202010_bib16","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1101\/gr.4023805","article-title":"Survey of allelic expression using EST mining","volume":"15","author":"Ge","year":"2005","journal-title":"Genome Res"},{"key":"10.1124\/jpet.112.202010_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/01.fpc.0000114754.08559.27","article-title":"Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver","volume":"14","author":"Girard","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1124\/jpet.112.202010_bib18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/hep.20770","article-title":"UGT1A1 polymorphisms are important determinants of dietary carcinogen detoxification in the liver","volume":"42","author":"Girard","year":"2005","journal-title":"Hepatology"},{"key":"10.1124\/jpet.112.202010_bib19","doi-asserted-by":"crossref","first-page":"12741","DOI":"10.1073\/pnas.220176997","article-title":"Increased resistance to acetaminophen hepatotoxicity in mice lacking glutathione S-transferase Pi","volume":"97","author":"Henderson","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.112.202010_bib20","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1124\/jpet.107.133306","article-title":"Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver","volume":"325","author":"Hofmann","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.202010_bib21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/dmd.106.014183","article-title":"UDP-Glucuronosyltransferase 1A1 gene polymorphisms and total bilirubin levels in an ethnically diverse cohort of women","volume":"35","author":"Hong","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.202010_bib22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/jpet.112.192658","article-title":"Quantification of hepatic UDP glucuronosyltransferase 1A splice variant expression and correlation of UDP glucuronosyltransferase 1A1 variant expression with glucuronidation activity","volume":"342","author":"Jones","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.202010_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.24060","article-title":"Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure","volume":"53","author":"Khandelwal","year":"2011","journal-title":"Hepatology"},{"key":"10.1124\/jpet.112.202010_bib24","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1124\/jpet.104.081950","article-title":"UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5\u2032-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation","volume":"313","author":"Krishnaswamy","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.202010_bib25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.cld.2007.06.006","article-title":"Acetaminophen hepatotoxicity","volume":"11","author":"Larson","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1124\/jpet.112.202010_bib26","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/hep.20948","article-title":"Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study","volume":"42","author":"Larson","year":"2005","journal-title":"Hepatology"},{"key":"10.1124\/jpet.112.202010_bib40","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/humu.20946","article-title":"Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population","volume":"30","author":"Menard","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1124\/jpet.112.202010_bib27","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1021\/tx050317i","article-title":"Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15: potential implications in acetaminophen-induced hepatotoxicity","volume":"19","author":"Mutlib","year":"2006","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/jpet.112.202010_bib28","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1124\/dmd.111.039149","article-title":"UGT1A6 and UGT2B15 polymorphisms and acetaminophen conjugation in response to a randomized, controlled diet of select fruits and vegetables","volume":"39","author":"Navarro","year":"2011","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.112.202010_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3109\/00498250903420243","article-title":"Identification of polymorphisms in the 3\u2032-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism","volume":"40","author":"Oleson","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.112.202010_bib30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1365-2125.1991.tb03988.x","article-title":"Interethnic differences in drug glucuronidation: a comparison of paracetamol metabolism in Caucasians and Chinese","volume":"32","author":"Osborne","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/jpet.112.202010_bib31","doi-asserted-by":"crossref","first-page":"947","DOI":"10.7326\/0003-4819-137-12-200212170-00007","article-title":"Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States","volume":"137","author":"Ostapowicz","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.112.202010_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00008571-199202000-00007","article-title":"Variability of acetaminophen metabolism in Caucasians and Orientals","volume":"2","author":"Patel","year":"1992","journal-title":"Pharmacogenetics"},{"key":"10.1124\/jpet.112.202010_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5414\/CPP42073","article-title":"Glucuronidation of acetaminophen is independent of UGT1A1 promotor genotype","volume":"42","author":"Rauchschwalbe","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1124\/jpet.112.202010_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.tpj.6500335","article-title":"Haplotype structures of the UGT1A gene complex in a Japanese population","volume":"6","author":"Saeki","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/jpet.112.202010_bib41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.clpt.2004.01.010","article-title":"UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer","volume":"75","author":"Sai","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.112.202010_bib35","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199710163371602","article-title":"Acetaminophen toxicity in an urban county hospital","volume":"337","author":"Schi\u00f8dt","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.112.202010_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/096032718700600512","article-title":"Paracetamol conjugation: an interethnic and dietary study","volume":"6","author":"Sommers","year":"1987","journal-title":"Hum Toxicol"},{"key":"10.1124\/jpet.112.202010_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1159\/000097908","article-title":"Effects of combined UDP-glucuronosyltransferase (UGT) 1A1*28 and 1A6*2 on paracetamol pharmacokinetics in beta-thalassemia\/HbE","volume":"79","author":"Tankanitlert","year":"2007","journal-title":"Pharmacology"},{"key":"10.1124\/jpet.112.202010_bib38","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/00498251003596817","article-title":"Role for protein kinase C delta in the functional activity of human UGT1A6: implications for drug-drug interactions between PKC inhibitors and UGT1A6","volume":"40","author":"Volak","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1124\/jpet.112.202010_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/03602532.2010.527984","article-title":"Paracetamol metabolism and related genetic differences","volume":"43","author":"Zhao","year":"2011","journal-title":"Drug Metab Rev"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.202010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:21:25Z","timestamp":1739985685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524185886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0022356524185886"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.202010","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The UDP-Glucuronosyltransferase (UGT) 1A Polymorphism c.2042C>G (rs8330) Is Associated with Increased Human Liver Acetaminophen Glucuronidation, Increased UGT1A Exon 5a\/5b Splice Variant mRNA Ratio, and Decreased Risk of Unintentional Acetaminophen-Induced Acute Liver Failure","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.202010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}